Document Detail

Sense and nonsense of high-dose cytarabine for acute myeloid leukemia.
MedLine Citation:
PMID:  23287624     Owner:  NLM     Status:  In-Data-Review    
High-dose cytarabine applied during remission induction or as consolidation after attainment of a complete remission has become an established element in the treatment of adults with acute myeloid leukemia. Recent evidence has challenged the need for these exceptionally high-dose levels of cytarabine. In this review, we present a reappraisal of the usefulness of high-dose cytarabine for acute myeloid leukemia treatment.
Bob Löwenberg
Related Documents :
24674034 - Intensity modulated radiation therapy planning for patients with a metal hip prosthesis...
22410804 - Novel tubulin polymerization inhibitors overcome multidrug resistance and reduce melano...
8468644 - Does the fibrin coat around a central venous catheter influence catheter-related sepsis?
24640204 - High or low- a trial of low dose anti snake venom in the treatment of poisonous snakebi...
18580704 - Croup management in australia and new zealand: a predict study of physician practice an...
3114784 - Comparison of nitrous oxide, morphine and diazepam effects in the mouse staircase test.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Blood     Volume:  121     ISSN:  1528-0020     ISO Abbreviation:  Blood     Publication Date:  2013 Jan 
Date Detail:
Created Date:  2013-01-04     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7603509     Medline TA:  Blood     Country:  United States    
Other Details:
Languages:  eng     Pagination:  26-8     Citation Subset:  AIM; IM    
Department of Hematology, Erasmus University Medical Center, Rotterdam, The Netherlands.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Association of celiac disease and cerebral venous thrombosis: Report of two cases.
Next Document:  Novel vaccine against Venezuelan equine encephalitis combines advantages of DNA immunization and a l...